Spear Bio is a Biotech company based in Woburn, Massachusetts. It has raised $49M in total funding. Latest round: Series A.
Spear Bio funding overview
Spear Bio is a Biotech company based in Woburn, Massachusetts. Spear Bio has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Spear Bio runs through 2024; nothing later has been disclosed. Investors on record include Foresite Capital, Bio-Techne Corporation, Maverick Ventures, Yonjin Capital, CDH Investments. 5 distinct backers are named across the disclosed rounds.
Spear Bio has raised $49M in total disclosed funding across the rounds on record.
Who has invested in Spear Bio?
Foresite Capital, Bio-Techne Corporation, Maverick Ventures, Yonjin Capital, CDH Investments are named among the investors backing Spear Bio.
What was the latest Spear Bio funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Spear Bio based?
Spear Bio is based in Woburn, Massachusetts.
What sector does Spear Bio operate in?
Spear Bio is tracked under Biotech from Woburn, Massachusetts, with $49M in disclosed funding.
When did Spear Bio last raise?
The last disclosed Spear Bio round closed in July 2024 at Series A.
We update the Spear Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Woburn and their backers are listed below.
